EMTRICITABINE Side Effects

5979668-4 | Abortion Spontaneous
on Nov 20, 2008 Female patient from HONG KONG , weighting 96.34 lb, was diagnosed with hepatitis b (What is hepatitis b?) and was treated with Emtricitabine (View Usage). Patient experienced the following unwanted or unexpected effects: abortion spontaneous. Emtricitabine dosage: . During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE (View Tenofovir Disoproxil Fumarate Review and Tenofovir Disoproxil Fumarate Label ). Patient was hospitalized.

5753031-3 | Stillbirth
Patient was taking Emtricitabine (View Usage). Patient had the following side effects: stillbirth on May 20, 2008 from UNITED STATES Additional patient health information: Female patient , 28 years of age, weighting 121.3 lb, was diagnosed with hiv infection (What is hiv infection?) and. Emtricitabine dosage: . During the same period patient was treated with EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE (200/300) (View Emtricitabine/tenofovir Disoproxil Fumarate Review and Emtricitabine/tenofovir Disoproxil Fumarate Label ), DIDANOSINE (View Didanosine Review and Didanosine Label ), ATAZANAVIR SULFATE (View Atazanavir Sulfate Review and Atazanavir Sulfate Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), NEVIRAPINE (View Nevirapine Review and Nevirapine Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ). Patient was hospitalized.

5732194-X | Pulmonary Tuberculosis
Adverse event was reported on Apr 29, 2008 by a Male patient taking Emtricitabine (View Usage) (Dosage: ) . Location: UNITED STATES , weighting 81.57 lb, After Emtricitabine was administered, patient had the following side effects: pulmonary tuberculosis. During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE (View Tenofovir Disoproxil Fumarate Review and Tenofovir Disoproxil Fumarate Label ), ATAZANAVIR SULFATE (View Atazanavir Sulfate Review and Atazanavir Sulfate Label ), STAVUDINE (View Stavudine Review and Stavudine Label ). Patient was hospitalized.

5728113-2 | Abortion Spontaneous
on Apr 29, 2008 Female patient from MALAWI , weighting 114.6 lb, was diagnosed with hiv infection (What is hiv infection?), contraception and was treated with Emtricitabine (View Usage). Patient experienced the following unwanted or unexpected effects: abortion spontaneous. Emtricitabine dosage: . During the same period patient was treated with DIDANOSINE (View Didanosine Review and Didanosine Label ), ATAZANAVIR SULFATE (View Atazanavir Sulfate Review and Atazanavir Sulfate Label ), DEPO PROVERA (View Depo-provera Review and Depo-provera Label ), DEPO PROVERA (View Depo-provera Review and Depo-provera Label ).


5605005-0 | Hepatic Enzyme Increased, Hepatic Steatosis, Hyperglycaemia
on Jan 17, 2008 Male patient from UNITED STATES , 14 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Emtricitabine (View Usage). Patient had the following side effects: hepatic enzyme increased, hepatic steatosis, hyperglycaemia. Emtricitabine dosage: . During the same period patient was treated with ATAZANAVIR SULFATE (View Atazanavir Sulfate Review and Atazanavir Sulfate Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), DIDANOSINE (View Didanosine Review and Didanosine Label ).

5603048-4 | Hyperbilirubinaemia
Patient was taking Emtricitabine (View Usage). After Emtricitabine was administered, patient had the following side effects: hyperbilirubinaemia on Jan 16, 2008 from UNITED STATES Additional patient health information: Female patient , 34 years of age, weighting 116.8 lb, was diagnosed with hiv infection (What is hiv infection?), pulmonary tuberculosis, medical diet and. Emtricitabine dosage: . During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE (View Tenofovir Disoproxil Fumarate Review and Tenofovir Disoproxil Fumarate Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), ISONIAZID (View Isoniazid Review and Isoniazid Label ), RIFAMPICIN (View Rifampicin Review and Rifampicin Label ), PYRAZINAMIDE (View Pyrazinamide Review and Pyrazinamide Label ), ETHAMBUTOL HYDROCHLORIDE (View Ethambutol Hydrochloride Review and Ethambutol Hydrochloride Label ), PYRIDOXINE (View Pyridoxine Review and Pyridoxine Label ). Patient was hospitalized.

5599150-6 | Stillbirth
Adverse event was reported on Jan 16, 2008 by a Female patient taking Emtricitabine (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: UNITED STATES , 28 years of age, weighting 121.3 lb, Patient experienced the following unwanted or unexpected effects: stillbirth. During the same period patient was treated with EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE (200/300) (View Emtricitabine/tenofovir Disoproxil Fumarate Review and Emtricitabine/tenofovir Disoproxil Fumarate Label ), DIDANOSINE (View Didanosine Review and Didanosine Label ), ATAZANAVIR SULFATE (View Atazanavir Sulfate Review and Atazanavir Sulfate Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), NEVIRAPINE (View Nevirapine Review and Nevirapine Label ), FERROUS SULFATE (View Ferrous Sulfate Review and Ferrous Sulfate Label ). Patient was hospitalized.

5587489-X | Stillbirth
on Dec 28, 2007 Female patient from UNITED STATES , 28 years of age, weighting 121.3 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Emtricitabine (View Usage). Patient had the following side effects: stillbirth. Emtricitabine dosage: . During the same period patient was treated with EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE (200/300) (View Emtricitabine/tenofovir Disoproxil Fumarate Review and Emtricitabine/tenofovir Disoproxil Fumarate Label ), DIDANOSINE (View Didanosine Review and Didanosine Label ), ATAZANAVIR SULFATE (View Atazanavir Sulfate Review and Atazanavir Sulfate Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), NEVIRAPINE (View Nevirapine Review and Nevirapine Label ), FERROUS SULFATE (View Ferrous Sulfate Review and Ferrous Sulfate Label ). Patient was hospitalized.

5574736-3 | Blood Albumin Decreased, Blood Potassium Decreased, Haematocrit Decreased, Haemoglobin Decreased, Malaria, Postpartum Haemorrhage, Pyrexia
on Dec 21, 2007 Female patient from UNITED STATES , 28 years of age, weighting 121.3 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Emtricitabine (View Usage). After Emtricitabine was administered, patient had the following side effects: blood albumin decreased, blood potassium decreased, haematocrit decreased, haemoglobin decreased, malaria (What is malaria?), postpartum haemorrhage, pyrexia. Emtricitabine dosage: 200 Mg Qd Po. During the same period patient was treated with DIDANOSINE (250 Mg Qd Po) (View Didanosine Review and Didanosine Label ), ATAZANAVIR SULFATE (400 Mg Qd Po) (View Atazanavir Sulfate Review and Atazanavir Sulfate Label ), TRUVADA (200/300 Mg Qd Po) (View Truvada Review and Truvada Label ), ZIDOVUDINE (300 Mg Bid Po) (View Zidovudine Review and Zidovudine Label ), NEVIRAPINE (200 Mg Bid Po) (View Nevirapine Review and Nevirapine Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ). Patient was hospitalized.

5571670-X | Stillbirth
Patient was taking Emtricitabine (View Usage). Patient experienced the following unwanted or unexpected effects: stillbirth on Dec 12, 2007 from UNITED STATES Additional patient health information: Female patient , 28 years of age, weighting 121.3 lb, was diagnosed with hiv infection (What is hiv infection?) and. Emtricitabine dosage: . During the same period patient was treated with EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE (200/300) (View Emtricitabine/tenofovir Disoproxil Fumarate Review and Emtricitabine/tenofovir Disoproxil Fumarate Label ), DIDANOSINE (View Didanosine Review and Didanosine Label ), ATAZANAVIR (View Atazanavir Review and Atazanavir Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), NEVIRAPINE (View Nevirapine Review and Nevirapine Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ). Patient was hospitalized.

5570160-8 | Hyperbilirubinaemia
Adverse event was reported on Dec 12, 2007 by a Female patient taking Emtricitabine (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?), pulmonary tuberculosis, medical diet and. Location: UNITED STATES , 34 years of age, weighting 116.8 lb, Patient had the following side effects: hyperbilirubinaemia. During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE (View Tenofovir Disoproxil Fumarate Review and Tenofovir Disoproxil Fumarate Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), ISONIAZID (View Isoniazid Review and Isoniazid Label ), RIFAMPICIN (View Rifampicin Review and Rifampicin Label ), PYRAZINAMIDE (View Pyrazinamide Review and Pyrazinamide Label ), ETHAMBUTOL HYDROCHLORIDE (View Ethambutol Hydrochloride Review and Ethambutol Hydrochloride Label ), PYRIDOXINE (View Pyridoxine Review and Pyridoxine Label ). Patient was hospitalized.

5537435-X | Abortion Spontaneous
on Nov 26, 2007 Female patient from UNITED STATES , 41 years of age, weighting 116.8 lb, was diagnosed with retroviral infection and was treated with Emtricitabine (View Usage). After Emtricitabine was administered, patient had the following side effects: abortion spontaneous. Emtricitabine dosage: . During the same period patient was treated with DIDANOSINE (View Didanosine Review and Didanosine Label ), ATAZANAVIR (View Atazanavir Review and Atazanavir Label ), BACTRIM (View Bactrim Review and Bactrim Label ), VITAMIN B (View Vitamin B Review and Vitamin B Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), IRON SULPHATE (View Iron Sulphate Review and Iron Sulphate Label ).

5537425-7 | Haemorrhage Intracranial
on Nov 26, 2007 Male patient from UNITED STATES , 29 years of age, weighting 143.3 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Emtricitabine (View Usage). Patient experienced the following unwanted or unexpected effects: haemorrhage intracranial. Emtricitabine dosage: . During the same period patient was treated with DDI (View Ddi Review and Ddi Label ), ATAZANAVIR (View Atazanavir Review and Atazanavir Label ), SULFAMETHOXAZOLE AND TRIMETHOTRIM (View Sulfamethoxazole And Trimethotrim Review and Sulfamethoxazole And Trimethotrim Label ), AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ). Patient was hospitalized.

5526098-5 | Dyspnoea, Pulmonary Tuberculosis
Patient was taking Emtricitabine (View Usage). Patient had the following side effects: dyspnoea, pulmonary tuberculosis on Nov 14, 2007 from UNITED STATES Additional patient health information: Female patient , 27 years of age, weighting 59.52 lb, was diagnosed with hiv infection (What is hiv infection?) and. Emtricitabine dosage: . During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE (View Tenofovir Disoproxil Fumarate Review and Tenofovir Disoproxil Fumarate Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), ISONIAZID (View Isoniazid Review and Isoniazid Label ), RIFAMPICIN (View Rifampicin Review and Rifampicin Label ), ETHAMBUTOL HYDROCHLORIDE (View Ethambutol Hydrochloride Review and Ethambutol Hydrochloride Label ), COTRIM (View Cotrim Review and Cotrim Label ), LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ). Patient was hospitalized.

5521391-4 | Abortion Spontaneous
Adverse event was reported on Nov 08, 2007 by a Female patient taking Emtricitabine (View Usage) (Dosage: ) was diagnosed with retroviral infection and. Location: UNITED STATES , 41 years of age, weighting 116.8 lb, After Emtricitabine was administered, patient had the following side effects: abortion spontaneous. During the same period patient was treated with DIDANOSINE (View Didanosine Review and Didanosine Label ), ATAZANAVIR SULFATE (View Atazanavir Sulfate Review and Atazanavir Sulfate Label ), BACTRIM (View Bactrim Review and Bactrim Label ), VITAMIN B (View Vitamin B Review and Vitamin B Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), IRON SULPHATE (View Iron Sulphate Review and Iron Sulphate Label ).

5521380-X | Paraplegia
on Nov 07, 2007 Female patient from UNITED STATES , 53 years of age, weighting 126.5 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Emtricitabine (View Usage). Patient experienced the following unwanted or unexpected effects: paraplegia. Emtricitabine dosage: . During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE (View Tenofovir Disoproxil Fumarate Review and Tenofovir Disoproxil Fumarate Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), GLIPIZIDE (View Glipizide Review and Glipizide Label ), VITAMINS (View Vitamins Review and Vitamins Label ), IRON (View Iron Review and Iron Label ). Patient was hospitalized.

5510837-3 | Immune Reconstitution Syndrome
on Nov 02, 2007 Male patient from UNITED STATES , 45 years of age, weighting 131.6 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Emtricitabine (View Usage). Patient had the following side effects: immune reconstitution syndrome. Emtricitabine dosage: . During the same period patient was treated with ATAZANAVIR SULFATE (View Atazanavir Sulfate Review and Atazanavir Sulfate Label ), DIDANOSINE (View Didanosine Review and Didanosine Label ), COTRIM (View Cotrim Review and Cotrim Label ), PYRIMETHAMINE (View Pyrimethamine Review and Pyrimethamine Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ). Patient was hospitalized.

5504240-X | Ascites
Patient was taking Emtricitabine (View Usage). After Emtricitabine was administered, patient had the following side effects: ascites on Oct 23, 2007 from UNITED STATES Additional patient health information: Male patient , 45 years of age, weighting 131.6 lb, was diagnosed with hiv infection (What is hiv infection?) and. Emtricitabine dosage: . During the same period patient was treated with ATAZANAVIR SULFATE (View Atazanavir Sulfate Review and Atazanavir Sulfate Label ), DIDANOSINE (View Didanosine Review and Didanosine Label ), CO TRIMOXAZOLE (View Co Trimoxazole Review and Co Trimoxazole Label ), PYRIMETHAMINE (View Pyrimethamine Review and Pyrimethamine Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ). Patient was hospitalized.

5482457-0 | Tuberculous Pleurisy
Adverse event was reported on Oct 05, 2007 by a Female patient taking Emtricitabine (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?), tuberculosis (What is tuberculosis?), influenza and. Location: UNITED STATES , 29 years of age, Patient experienced the following unwanted or unexpected effects: tuberculous pleurisy. During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE (View Tenofovir Disoproxil Fumarate Review and Tenofovir Disoproxil Fumarate Label ), NEVIRAPINE (View Nevirapine Review and Nevirapine Label ), ISONIAZID (View Isoniazid Review and Isoniazid Label ), RIFAMPICIN (View Rifampicin Review and Rifampicin Label ), PYRAZINAMIDE (View Pyrazinamide Review and Pyrazinamide Label ), ETHAMBUTOL HCL (View Ethambutol Hcl Review and Ethambutol Hcl Label ), AMOXYL (View Amoxyl Review and Amoxyl Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ).

5467210-6 | Paraplegia
on Aug 16, 2007 Female patient from UNITED STATES , 53 years of age, weighting 126.5 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Emtricitabine (View Usage). Patient had the following side effects: paraplegia. Emtricitabine dosage: . During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE (View Tenofovir Disoproxil Fumarate Review and Tenofovir Disoproxil Fumarate Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), GLIPIZIDE (View Glipizide Review and Glipizide Label ), VITAMINS (View Vitamins Review and Vitamins Label ), IRON (View Iron Review and Iron Label ). Patient was hospitalized.

5457496-6 | Dyspnoea, Pulmonary Tuberculosis
on Sep 11, 2007 Female patient from UNITED STATES , 27 years of age, weighting 59.52 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Emtricitabine (View Usage). After Emtricitabine was administered, patient had the following side effects: dyspnoea, pulmonary tuberculosis. Emtricitabine dosage: . During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE (View Tenofovir Disoproxil Fumarate Review and Tenofovir Disoproxil Fumarate Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), ISONIAZID (View Isoniazid Review and Isoniazid Label ), RIFAMPICIN (View Rifampicin Review and Rifampicin Label ), ETHAMBUTOL (View Ethambutol Review and Ethambutol Label ), COTRIMOXAZOLE (View Cotrimoxazole Review and Cotrimoxazole Label ), LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ). Patient was hospitalized.

5457447-4 | Haemorrhage Intracranial
Patient was taking Emtricitabine (View Usage). Patient experienced the following unwanted or unexpected effects: haemorrhage intracranial on Sep 11, 2007 from UNITED STATES Additional patient health information: Male patient , 29 years of age, weighting 143.3 lb, was diagnosed with hiv infection (What is hiv infection?) and. Emtricitabine dosage: . During the same period patient was treated with DDI (View Ddi Review and Ddi Label ), ATAZANAVIR SULFATE (View Atazanavir Sulfate Review and Atazanavir Sulfate Label ), SULFAMETHOXAZOLE AND TRIMETHOTRIM (View Sulfamethoxazole And Trimethotrim Review and Sulfamethoxazole And Trimethotrim Label ), AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ). Patient was hospitalized.

5457446-2 |
Adverse event was reported on Sep 11, 2007 by a Male patient taking Emtricitabine (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: UNITED STATES , 41 years of age, weighting 129.0 lb, . During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE (View Tenofovir Disoproxil Fumarate Review and Tenofovir Disoproxil Fumarate Label ), ATAZANAVIR SULFATE (View Atazanavir Sulfate Review and Atazanavir Sulfate Label ), KALETRA (View Kaletra Review and Kaletra Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ), BUSCOPAN (View Buscopan Review and Buscopan Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ).

5456425-9 | Subarachnoid Haemorrhage
on Sep 11, 2007 Female patient from UNITED STATES , 36 years of age, weighting 209.4 lb, was diagnosed with hiv infection (What is hiv infection?), contraception, anaemia, helminthic infection and was treated with Emtricitabine (View Usage). After Emtricitabine was administered, patient had the following side effects: subarachnoid haemorrhage. Emtricitabine dosage: . During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE (View Tenofovir Disoproxil Fumarate Review and Tenofovir Disoproxil Fumarate Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), MICROGYNON (View Microgynon Review and Microgynon Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), ALBENDAZOLE (View Albendazole Review and Albendazole Label ), VITAMIN CAP (View Vitamin Cap Review and Vitamin Cap Label ), MAGNESIUM SULFATE (View Magnesium Sulfate Review and Magnesium Sulfate Label ).

5456403-X |
on Sep 11, 2007 Female patient from UNITED STATES , 40 years of age, weighting 136.1 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Emtricitabine (View Usage). . Emtricitabine dosage: . During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE (View Tenofovir Disoproxil Fumarate Review and Tenofovir Disoproxil Fumarate Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), SULFAMETHOXAZOLE AND TRIMETHOPRIM (View Sulfamethoxazole And Trimethoprim Review and Sulfamethoxazole And Trimethoprim Label ), IRON PREPARATIONS (View Iron Preparations Review and Iron Preparations Label ), VITAMIN B COMPLEX CAP (View Vitamin B Complex Cap Review and Vitamin B Complex Cap Label ).

5451579-2 | Abasia, Abdominal Pain, Anaemia, Anorexia, Blood Albumin Decreased, Blood Potassium Decreased, Bronchitis, Cachexia, Confusional State
Patient was taking Emtricitabine (View Usage). Patient had the following side effects: abasia, abdominal pain (What is abdominal pain?), anaemia, anorexia, blood albumin decreased, blood potassium decreased, bronchitis (What is bronchitis?), cachexia, confusional state on Sep 04, 2007 from UNITED STATES Additional patient health information: Female patient , 34 years of age, weighting 94.80 lb, was diagnosed with hiv infection (What is hiv infection?) and. Emtricitabine dosage: . During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE (Oral) (View Tenofovir Disoproxil Fumarate Review and Tenofovir Disoproxil Fumarate Label ), KALETRA (View Kaletra Review and Kaletra Label ), LOPERAMIDE HCL (View Loperamide Hcl Review and Loperamide Hcl Label ), MICONAZOLE ORAL GEL (View Miconazole Oral Gel Review and Miconazole Oral Gel Label ), CIPROFOXAN (View Ciprofoxan Review and Ciprofoxan Label ). Patient was hospitalized.

5449026-X | Haemorrhage Intracranial
Adverse event was reported on Sep 06, 2007 by a Male patient taking Emtricitabine (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: UNITED STATES , 29 years of age, weighting 143.3 lb, After Emtricitabine was administered, patient had the following side effects: haemorrhage intracranial. During the same period patient was treated with DDI (View Ddi Review and Ddi Label ), ATAZANAVIR SULFATE (View Atazanavir Sulfate Review and Atazanavir Sulfate Label ), SULFAMETHOXAZOLE AND TRIMETHOTRIM (View Sulfamethoxazole And Trimethotrim Review and Sulfamethoxazole And Trimethotrim Label ), AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ). Patient was hospitalized.

5440786-0 | Pancreatitis
on Aug 21, 2007 Female patient from UNITED STATES , 31 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Emtricitabine (View Usage). Patient experienced the following unwanted or unexpected effects: pancreatitis. Emtricitabine dosage: . During the same period patient was treated with DIDANOSINE (View Didanosine Review and Didanosine Label ), ATAZANAVIR SULFATE (View Atazanavir Sulfate Review and Atazanavir Sulfate Label ), ETHAMBUTOL HYDROCHLORIDE (View Ethambutol Hydrochloride Review and Ethambutol Hydrochloride Label ), INH (View Inh Review and Inh Label ), SULFAMETHOXAZOLE + TRIMETHOPRIM (View Sulfamethoxazole + Trimethoprim Review and Sulfamethoxazole + Trimethoprim Label ). Patient was hospitalized.

5426993-1 | Anaemia, Hiv Infection
on Aug 22, 2007 Female patient from UNITED STATES , 34 years of age, weighting 94.80 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Emtricitabine (View Usage). Patient had the following side effects: anaemia, hiv infection (What is hiv infection?). Emtricitabine dosage: . During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE (Oral) (View Tenofovir Disoproxil Fumarate Review and Tenofovir Disoproxil Fumarate Label ), KALETRA (View Kaletra Review and Kaletra Label ), LOPERAMIDE HCL (View Loperamide Hcl Review and Loperamide Hcl Label ), MICONAZOLE ORAL GEL (View Miconazole Oral Gel Review and Miconazole Oral Gel Label ), CIPROFOXAN (View Ciprofoxan Review and Ciprofoxan Label ). Patient was hospitalized.

5422895-5 | Dyspnoea, Pulmonary Tuberculosis
Patient was taking Emtricitabine (View Usage). After Emtricitabine was administered, patient had the following side effects: dyspnoea, pulmonary tuberculosis on Aug 13, 2007 from UNITED STATES Additional patient health information: Female patient , 27 years of age, weighting 59.52 lb, was diagnosed with hiv infection (What is hiv infection?) and. Emtricitabine dosage: . During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE (View Tenofovir Disoproxil Fumarate Review and Tenofovir Disoproxil Fumarate Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), ISONIAZID (View Isoniazid Review and Isoniazid Label ), RIFAMPICIN (View Rifampicin Review and Rifampicin Label ), ETHAMBUTOL HYDROCHLORIDE (View Ethambutol Hydrochloride Review and Ethambutol Hydrochloride Label ), COTRIM (View Cotrim Review and Cotrim Label ), LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ). Patient was hospitalized.

5420335-3 | Stevens-johnson Syndrome
Adverse event was reported on Aug 09, 2007 by a Male patient taking Emtricitabine (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?), pyrexia and. Location: UNITED STATES , 50 years of age, weighting 101.4 lb, Patient experienced the following unwanted or unexpected effects: stevens-johnson syndrome. During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE (View Tenofovir Disoproxil Fumarate Review and Tenofovir Disoproxil Fumarate Label ), NEVIRAPINE (View Nevirapine Review and Nevirapine Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), PCM (View Pcm Review and Pcm Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ).

5420242-6 | Cerebral Infarction, Dilatation Ventricular, Sinus Bradycardia
on Aug 10, 2007 Male patient from UNITED STATES , 26 years of age, weighting 107.7 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Emtricitabine (View Usage). Patient had the following side effects: cerebral infarction, dilatation ventricular, sinus bradycardia. Emtricitabine dosage: . During the same period patient was treated with DDI EC (View Ddi-ec Review and Ddi-ec Label ), DDI EC (View Ddi-ec Review and Ddi-ec Label ), ATAZANAVIR SULFATE (View Atazanavir Sulfate Review and Atazanavir Sulfate Label ), TRIAMCINOLONE (View Triamcinolone Review and Triamcinolone Label ), CLINDAMYCIN HCL (View Clindamycin Hcl Review and Clindamycin Hcl Label ), PRIMAQUINE (View Primaquine Review and Primaquine Label ). Patient was hospitalized.

5417457-X |
on Aug 13, 2007 Male patient from UNITED STATES , 41 years of age, weighting 129.0 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Emtricitabine (View Usage). . Emtricitabine dosage: . During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE (View Tenofovir Disoproxil Fumarate Review and Tenofovir Disoproxil Fumarate Label ), ATAZANAVIR SULFATE (View Atazanavir Sulfate Review and Atazanavir Sulfate Label ), KALETRA (View Kaletra Review and Kaletra Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ), BUSCOPAN (View Buscopan Review and Buscopan Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ).

5416065-4 |
Patient was taking Emtricitabine (View Usage). on Aug 14, 2007 from UNITED STATES Additional patient health information: Female patient , 40 years of age, weighting 136.1 lb, was diagnosed with hiv infection (What is hiv infection?) and. Emtricitabine dosage: . During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE (View Tenofovir Disoproxil Fumarate Review and Tenofovir Disoproxil Fumarate Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), SULFAMETHOXAZOLE AND TRIMETHOPRIM (View Sulfamethoxazole And Trimethoprim Review and Sulfamethoxazole And Trimethoprim Label ), IRON PREPARATIONS (View Iron Preparations Review and Iron Preparations Label ), VITAMIN B COMPLEX CAP (View Vitamin B Complex Cap Review and Vitamin B Complex Cap Label ).

5412846-1 | Paraplegia
Adverse event was reported on Aug 09, 2007 by a Female patient taking Emtricitabine (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: UNITED STATES , 53 years of age, weighting 126.5 lb, Patient had the following side effects: paraplegia. During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE (View Tenofovir Disoproxil Fumarate Review and Tenofovir Disoproxil Fumarate Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), GLIPIZIDE (View Glipizide Review and Glipizide Label ), MULTIVITAMIN (View Multivitamin Review and Multivitamin Label ), IRON (View Iron Review and Iron Label ). Patient was hospitalized.

5412839-4 | Hepatitis
on Aug 09, 2007 Female patient from UNITED STATES , 37 years of age, weighting 161.8 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Emtricitabine (View Usage). After Emtricitabine was administered, patient had the following side effects: hepatitis (What is hepatitis?). Emtricitabine dosage: . During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE (View Tenofovir Disoproxil Fumarate Review and Tenofovir Disoproxil Fumarate Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ). Patient was hospitalized.

5412836-9 | Convulsion
on Aug 02, 2007 Male patient from UNITED STATES , 29 years of age, weighting 143.3 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Emtricitabine (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion. Emtricitabine dosage: . During the same period patient was treated with DDI (View Ddi Review and Ddi Label ), ATAZANAVIR SULFATE (View Atazanavir Sulfate Review and Atazanavir Sulfate Label ), SULFAMETHOXAZOLE AND TRIMETHOTRIM (View Sulfamethoxazole And Trimethotrim Review and Sulfamethoxazole And Trimethotrim Label ), AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ). Patient was hospitalized.

5404559-7 | Blood Creatinine Increased
Patient was taking Emtricitabine (View Usage). Patient had the following side effects: blood creatinine increased on Jul 25, 2007 from UNITED STATES Additional patient health information: Male patient , 32 years of age, weighting 115.1 lb, was diagnosed with hiv infection (What is hiv infection?), prophylaxis and. Emtricitabine dosage: . During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE (View Tenofovir Disoproxil Fumarate Review and Tenofovir Disoproxil Fumarate Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), VITAMIN CAP (View Vitamin Cap Review and Vitamin Cap Label ), ASCORBIC ACID (View Ascorbic Acid Review and Ascorbic Acid Label ), SULFAMETHOXAZOLE AND TRIMETHOPRIM (View Sulfamethoxazole And Trimethoprim Review and Sulfamethoxazole And Trimethoprim Label ). Patient was hospitalized.

5392458-9 | Anaemia
Adverse event was reported on Jul 10, 2007 by a Female patient taking Emtricitabine (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: UNITED STATES , 34 years of age, weighting 94.80 lb, After Emtricitabine was administered, patient had the following side effects: anaemia. During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE (Oral) (View Tenofovir Disoproxil Fumarate Review and Tenofovir Disoproxil Fumarate Label ), KALETRA (View Kaletra Review and Kaletra Label ), CIPROFOXAN (View Ciprofoxan Review and Ciprofoxan Label ), LOPERAMIDE HCL (View Loperamide Hcl Review and Loperamide Hcl Label ), MICONAZOLE ORAL GEL (View Miconazole Oral Gel Review and Miconazole Oral Gel Label ). Patient was hospitalized.

5382360-0 | Dyspnoea, Pulmonary Tuberculosis
on Jun 28, 2007 Female patient from UNITED STATES , 27 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Emtricitabine (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea, pulmonary tuberculosis. Emtricitabine dosage: . During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE (View Tenofovir Disoproxil Fumarate Review and Tenofovir Disoproxil Fumarate Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), ISONIAZID (View Isoniazid Review and Isoniazid Label ), RIFAMPICIN (View Rifampicin Review and Rifampicin Label ), ETHAMBUTOL HYDROCHLORIDE (View Ethambutol Hydrochloride Review and Ethambutol Hydrochloride Label ), COTRIM (View Cotrim Review and Cotrim Label ), LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ). Patient was hospitalized.

5351504-9 | Abortion Infected
on Jun 04, 2007 Female patient from UNITED STATES , weighting 114.6 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Emtricitabine (View Usage). Patient had the following side effects: abortion infected. Emtricitabine dosage: . During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE (View Tenofovir Disoproxil Fumarate Review and Tenofovir Disoproxil Fumarate Label ), KALETRA (View Kaletra Review and Kaletra Label ). Patient was hospitalized.

5349939-3 | Tuberculosis Gastrointestinal
Patient was taking Emtricitabine (View Usage). After Emtricitabine was administered, patient had the following side effects: tuberculosis gastrointestinal on May 30, 2007 from UNITED STATES Additional patient health information: Female patient , 28 years of age, was diagnosed with hiv infection (What is hiv infection?), bacillus infection, colonoscopy (What is colonoscopy?) and. Emtricitabine dosage: . During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE (View Tenofovir Disoproxil Fumarate Review and Tenofovir Disoproxil Fumarate Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), PENTOPRAZOLE (View Pentoprazole Review and Pentoprazole Label ), MAXAMIN FORTE (View Maxamin Forte Review and Maxamin Forte Label ), DULCOLAX (View Dulcolax Review and Dulcolax Label ). Patient was hospitalized.

5346140-4 | Hyperbilirubinaemia
Adverse event was reported on May 31, 2007 by a Male patient taking Emtricitabine (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: UNITED STATES , 33 years of age, weighting 143.3 lb, Patient experienced the following unwanted or unexpected effects: hyperbilirubinaemia. During the same period patient was treated with ATAZANAVIR SULFATE (View Atazanavir Sulfate Review and Atazanavir Sulfate Label ), DIDANOSINE (View Didanosine Review and Didanosine Label ), CETIRIZINE HCL (View Cetirizine Hcl Review and Cetirizine Hcl Label ).

5320735-6 | Abdominal Pain Upper, Band Neutrophil Percentage Increased, Blood Albumin Decreased, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Blood Creatinine Increased, Blood Phosphorus Increased, Blood Potassium Decreased, Cough
on May 01, 2007 Male patient from UNITED STATES , 32 years of age, weighting 115.1 lb, was diagnosed with hiv infection (What is hiv infection?), prophylaxis and was treated with Emtricitabine (View Usage). Patient had the following side effects: abdominal pain upper, band neutrophil percentage increased, blood albumin decreased, blood alkaline phosphatase increased, blood bilirubin increased, blood creatinine increased, blood phosphorus increased, blood potassium decreased, cough. Emtricitabine dosage: . During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE (View Tenofovir Disoproxil Fumarate Review and Tenofovir Disoproxil Fumarate Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), VITAMIN CAP (View Vitamin Cap Review and Vitamin Cap Label ), ASCORBIC ACID (View Ascorbic Acid Review and Ascorbic Acid Label ), SULFAMETHOXAZOLE AND TRIMETHOPRIM (View Sulfamethoxazole And Trimethoprim Review and Sulfamethoxazole And Trimethoprim Label ). Patient was hospitalized.

5312729-1 | Hepatitis
on Apr 20, 2007 Female patient from UNITED STATES , 40 years of age, weighting 144.2 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Emtricitabine (View Usage). After Emtricitabine was administered, patient had the following side effects: hepatitis (What is hepatitis?). Emtricitabine dosage: . During the same period patient was treated with ATAZANAVIR SULFATE (View Atazanavir Sulfate Review and Atazanavir Sulfate Label ), DIDANOSINE (View Didanosine Review and Didanosine Label ), MEDROXYPROGESTERONE ACETATE (View Medroxyprogesterone Acetate Review and Medroxyprogesterone Acetate Label ).

5312727-8 | Hepatitis
Patient was taking Emtricitabine (View Usage). Patient experienced the following unwanted or unexpected effects: hepatitis (What is hepatitis?) on Apr 20, 2007 from UNITED STATES Additional patient health information: Female patient , 37 years of age, weighting 161.8 lb, was diagnosed with hiv infection (What is hiv infection?) and. Emtricitabine dosage: . During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE (View Tenofovir Disoproxil Fumarate Review and Tenofovir Disoproxil Fumarate Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ). Patient was hospitalized.

5304680-8 | Diastolic Hypertension, Hypersensitivity, Meningitis Cryptococcal, Subarachnoid Haemorrhage
Adverse event was reported on Apr 12, 2007 by a Female patient taking Emtricitabine (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?), contraception, anaemia, helminthic infection and. Location: UNITED STATES , 36 years of age, weighting 209.4 lb, Patient had the following side effects: diastolic hypertension, hypersensitivity, meningitis cryptococcal, subarachnoid haemorrhage. During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE (View Tenofovir Disoproxil Fumarate Review and Tenofovir Disoproxil Fumarate Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), MICROGYNON (View Microgynon Review and Microgynon Label ), FERROUS SULFATE (View Ferrous Sulfate Review and Ferrous Sulfate Label ), ALBENDAZOLE (View Albendazole Review and Albendazole Label ), VITAMIN CAP (View Vitamin Cap Review and Vitamin Cap Label ), MAGNESIUM (View Magnesium Review and Magnesium Label ).

5303659-X | Aspartate Aminotransferase Increased, Confusional State, Palpitations, Psychotic Disorder, Stevens-johnson Syndrome
on Apr 10, 2007 Male patient from UNITED STATES , 50 years of age, weighting 105.8 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Emtricitabine (View Usage). After Emtricitabine was administered, patient had the following side effects: aspartate aminotransferase increased, confusional state, palpitations, psychotic disorder (What is psychotic disorder?), stevens-johnson syndrome. Emtricitabine dosage: . During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE (View Tenofovir Disoproxil Fumarate Review and Tenofovir Disoproxil Fumarate Label ), NEVIRAPINE (View Nevirapine Review and Nevirapine Label ), FERROUS SULFATE (View Ferrous Sulfate Review and Ferrous Sulfate Label ).

5286891-3 | Hepatitis
on Apr 03, 2007 Female patient from UNITED STATES , 37 years of age, weighting 161.8 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Emtricitabine (View Usage). Patient experienced the following unwanted or unexpected effects: hepatitis (What is hepatitis?). Emtricitabine dosage: . During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE (View Tenofovir Disoproxil Fumarate Review and Tenofovir Disoproxil Fumarate Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ). Patient was hospitalized.

5274194-2 | Pneumonia Bacterial
Patient was taking Emtricitabine (View Usage). Patient had the following side effects: pneumonia bacterial on Mar 19, 2007 from UNITED STATES Additional patient health information: Female patient , weighting 119.0 lb, was diagnosed with hiv infection (What is hiv infection?), anaemia and. Emtricitabine dosage: . During the same period patient was treated with DIDANOSINE (View Didanosine Review and Didanosine Label ), ATAZANAVIR SULFATE (View Atazanavir Sulfate Review and Atazanavir Sulfate Label ), BACTRIM (View Bactrim Review and Bactrim Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ). Patient was hospitalized.